Thomas Ulich

2017

In 2017, Thomas Ulich earned a total compensation of $1.2M as Former Chief Scientific Officer at InVivo Therapeutics Holdings, a 149% increase compared to previous year.

Compensation breakdown

Option Awards$533,873
Salary$254,788
Other$367,020
Total$1,155,681

Ulich received $533.9K in option awards, accounting for 46% of the total pay in 2017.

Ulich also received $254.8K in salary and $367K in other compensation.

Rankings

In 2017, Thomas Ulich's compensation ranked 8,275th out of 14,666 executives tracked by ExecPay. In other words, Ulich earned more than 43.6% of executives.

ClassificationRankingPercentile
All
8,275
out of 14,666
44th
Division
Manufacturing
3,132
out of 5,772
46th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
414
out of 859
52nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
222
out of 531
58th
Industry
Surgical and Medical Instruments and Apparatus
135
out of 336
60th
Source: SEC filing on April 27, 2018.

Ulich's colleagues

We found six more compensation records of executives who worked with Thomas Ulich at InVivo Therapeutics Holdings in 2017.

2017

Mark Perrin

InVivo Therapeutics Holdings

Chief Executive Officer

2017

Richard Toselli

InVivo Therapeutics Holdings

Chief Executive Officer

2017

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

2017

Christopher McNulty

InVivo Therapeutics Holdings

Chief Financial Officer

2017

Pamela Stahl

InVivo Therapeutics Holdings

Former Chief Commercial Officer

2017

Melanie Morel-Ferris

InVivo Therapeutics Holdings

Chief Financial Officer

You may also like